View in EDS

107P Safety and efficacy of trifluridine/tipiracil (FTD/TPI) in previously treated metastatic colorectal cancer (mCRC): Results from the Australian cohort of the phase IIIb, international, open-label, early-access PRECONNECT study.

Saved in:
Bibliographic Details
Title: 107P Safety and efficacy of trifluridine/tipiracil (FTD/TPI) in previously treated metastatic colorectal cancer (mCRC): Results from the Australian cohort of the phase IIIb, international, open-label, early-access PRECONNECT study.
Authors: Price, T.J.1, Burge, M.2, Chantrill, L.3, Chua, Y.J.4, Horvath, L.5, McLachlan, S-A.6, Pavlakis, N.7, Shapiro, J.8, Thavaneswaran, S.9, Tran, B.10, Yip, D.4, Tancock, G.11
Source: Annals of Oncology. 2020 Supplement 6, Vol. 31, pS1283-S1283. 1p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2020.10.127